Literature DB >> 2554155

Ventricular and atrial electrophysiological effects of a IC antiarrhythmic drug, cibenzoline, in the innervated dog heart. Role of sodium and calcium channels.

Q Timour1, J F Aupetit, J Loufoua-Moundanga, L Bertrix, M Freysz, G Faucon.   

Abstract

The effects of cibenzoline, rightly known as a sodium channel inhibitor (class IC antiarrhythmic drug), were investigated in anaesthetized, closed-chest dogs, on conduction in the contractile fibres, ventricular and atrial, the His-Purkinje system and the atrioventricular node. In ventricular muscle, conduction time was measured between base and apex by two endocavitary electrodes. The other conduction times were obtained from the recording of the His bundle potentials. In addition, effective refractory period was determined by the extrastimulus method in ventricular and atrial muscle and in the atrioventricular node, and sinus rate monitored in the intervals of pacing periods. In the absence of vagal tone, cibenzoline in 4 mg.kg-1 dose prolonged conduction times in the ventricular contractile tissue, His-Purkinje system and atrial contractile tissue to a large extent, but decreasingly from the former to the latter. This prolongation was antagonized by hypernatremia (174 mmol.l-1). In contrast, conduction time in the atrioventricular node, effective refractory periods and sinus rate were very little influenced. In the presence of vagal tone, the prolongation of conduction times in the ventricular contractile tissue. His-Purkinje system and atrial contractile tissue did not differ substantially from previously. It was the same for ventricular effective refractory period. But atrial effective refractory period was then considerably lengthened, while conduction time and effective refractory period in the atrioventricular node were greatly shortened and sinus rate notably accelerated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554155     DOI: 10.1007/BF00168520

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Auricular fibrillation induced and maintained in animals by acetylcholine or vagal stimulation.

Authors:  T A LOOMIS; S KROP
Journal:  Circ Res       Date:  1955-07       Impact factor: 17.367

2.  Biphasic dose-response relationship observed with Bay k 8644 on atrioventricular nodal conduction inhibited by verapamil.

Authors:  J Lang; Q Timour; J P Lançon; J F Aupetit; G Faucon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

Review 3.  Analysis of the effects of changes in rate and rhythm upon electrical activity in the heart.

Authors:  M R Boyett; B R Jewell
Journal:  Prog Biophys Mol Biol       Date:  1980       Impact factor: 3.667

4.  Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation.

Authors:  S B Olsson; N Edvardsson
Journal:  Am Heart J       Date:  1981-11       Impact factor: 4.749

5.  Inadvertent massive lidocaine overdose causing temporary complete heart block in myocardial infarction.

Authors:  E Badui; D Garcia-Rubi; B Estañol
Journal:  Am Heart J       Date:  1981-10       Impact factor: 4.749

6.  Electrophysiological effects of a new antiarrhythmic agent, flecainide, on the intact canine heart.

Authors:  A B Hodess; W P Follansbee; J F Spear; E N Moore
Journal:  J Cardiovasc Pharmacol       Date:  1979 Jul-Aug       Impact factor: 3.105

7.  Effects of acetylcholine on potassium movements in the guinea-pig sinus node.

Authors:  S L Lipsius; M Vassalle
Journal:  J Pharmacol Exp Ther       Date:  1977-06       Impact factor: 4.030

8.  Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia.

Authors:  J S Millar; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

9.  Influence of the restoration of vagal tone by intracisternal injection of dextromoramide on the cardiac effects of the antiarrhythmic drugs.

Authors:  L Bertrix; B Bui-Xuan; J Lang; K Bouzouita; Q Timour-Chah; G Faucon
Journal:  J Pharmacol       Date:  1983 Jul-Sep

10.  Effects of cibenzoline, a novel antiarrhythmic drug, on action potential and transmembrane currents in frog atrial muscle.

Authors:  C Masse; M Cazes; A Sassine
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-06
View more
  3 in total

1.  Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.

Authors:  J F Aupetit; Q Timour; J P Larbre; J Loufoua-Moundanga; I Kioueh; M Lopez; G Faucon
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

Review 2.  Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias.

Authors:  D W Harron; R N Brogden; D Faulds; A Fitton
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

3.  Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.

Authors:  Q Timour; J F Aupetit; J Loufoua-Moundanga; I Gerentes-Chassagne; I Kioueh; G Faucon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.